Gut microbiota signatures may predict how individuals respond to primary treatment for Clostridium difficile infection
28 Nov 2016by Andreu Prados
A recent study, led by Dr. Purna C. Kashyap from the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester (USA), has found that gut microbiota signatures may allow identification of patients with Clostridium difficile infection who will respond to initial treatment.